Heart failure in China: A review of the literature

Drugs

Volumn 73, Issue 7, 2013, Pages 689-701

  Ariely, Rinat ^a   Evans, Keith ^b   Mills, Tim ^c  

^a GLAXOSMITHKLINE   (United States)

^b InScience Communications   (United Kingdom)

^c AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; AMINOPHYLLINE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LANATOSIDE C; LOOP DIURETIC AGENT; MATRIX METALLOPROTEINASE; MORPHINE; NITRATE;

CARDIAC RESYNCHRONIZATION THERAPY; CHINA; CONGENITAL HEART DISEASE; CONGESTIVE CARDIOMYOPATHY; COR PULMONALE; DEFIBRILLATOR; GENETIC POLYMORPHISM; HAPLOTYPE; HEALTH CARE COST; HEART ASSIST DEVICE; HEART FAILURE; HEART TRANSPLANTATION; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; OXYGEN THERAPY; PREVALENCE; QUALITY OF LIFE; REVIEW; RHEUMATIC HEART DISEASE; RISK FACTOR; RURAL AREA; SINGLE NUCLEOTIDE POLYMORPHISM; SOCIAL STATUS; VALVULAR HEART DISEASE;

CHINA; DISEASE MANAGEMENT; HEALTH STATUS; HEART FAILURE; HUMANS; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; QUALITY OF LIFE; RISK FACTORS;

EID: 84878660885     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.1007/s40265-013-0057-8     Document Type: Review

References (45)

1. Haley DR, Zhao M, Nolin JM, Dunning K, Qiang S. Five myths of the Chinese health care system. Health Care Manage. 2008;27(2):147-58. doi: 10.1097/01.HCM.0000285042.42537.68.
2. Pan X, Dib HH, Wang X, Zhang H. Service utilization in community health centers in China: a comparison analysis with local hospitals. BMC Health Serv Res. 2006;6:93. doi: 10.1186/472-6963-6-93.
3. Wannian L, Chan, DKY. Community health care reform and general practice training in China - lessons learned Medical Education Online; 2004. p. 10.
4. National Development and Reform Commission China. Full text: report on China's Economic and Social Development Plan. National Development and Reform Commission, China; 2012. http://www.china.org.cn/china/NPC-CPPCC-2012/2012-03/ 14/content-24893766.htm (17 May 2012).
5. Li L. The challenges of healthcare reforms in China. Public Health. 2011;125(1):6-8. doi: 10.1016/j.puhe.2010.10.010.
6. Meng Q, Xu L, Zhang Y, Qian J, Cai M, Xin Y et al. Trends in access to health services and financial protection in China between 2003 and 2011: a cross-sectional study. [Erratum appears in Lancet. 2012 Sep 8;380(9845):888]. Lancet. 2012;379(9818):805-14. doi: 10.1016/S0140-6736(12)60278-5.
7. Ling RE, Liu F, Lu XQ, Wang W. Emerging issues in public health: a perspective on China's healthcare system. Public Health. 2011;125(1):9-14. doi: 10.1016/j.puhe.2010.10.009.
8. Joshi R, Jan S, Wu Y, MacMahon S. Global inequalities in access to cardiovascular health care: our greatest challenge. J Am Coll Cardiol. 2008;52(23):1817-25. doi: 10.1016/j.jacc.2008.08.049.
9. World Health Organization. Deaths from coronary heart disease; 2008.
10. Popkin BM. Will China's nutrition transition overwhelm its health care system and slow economic growth? Health Affairs. 2008;27(4):1064-76. doi: 10.1377/hlthaff.27.4.1064.
11. Cao Y, Digiacomo M, Du HY, Davidson PM. Chinese nurses' perceptions of heart health issues facing women in China: a focus group study. J Cardiovasc Nursing. 2009;24(6):E23-9. doi: 10.1097/JCN.0b013e3181b7006a.
12. He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, et al. Major causes of death among men and women in China. N Engl J Med. 2005;353(11):1124-34. doi: 10.1056/NEJMsa050467.
13. Guindon GE, Lavis JN, Becerra-Posada F, Malek-Afzali H, Shi G, Yesudian CA, et al. Bridging the gaps between research, policy and practice in low- and middle-income countries: a survey of health care providers. Can Med Assoc J. 2010;182(9):E362-72.
14. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29(19):2388-442. doi: 10.1093/eurheartj/ehn309.
15. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults. Circulation. 2009;119:e391-479.
16. Jiang H, Ge J. Epidemiology and clinical management of cardiomyopathies and heart failure in China. Heart. 2009;95(21):1727-31. doi: 10.1136/hrt.2008.150177.
17. Zile MR. Heart failure with preserved ejection fraction: is this diastolic heart failure? J Am Coll Cardiol. 2003;41(9):1519-22.
18. Gu D-F, Huang G-Y, J. H. Investigation of prevalence and distributing feature of chronic heart failure in Chinese adult population. Zhonghua Xin Xue Guan Bing Za Zhi [Chinese J Cardiol]. 2003;31(1):3-6.
19. Shanghai Investigation Group of Heart Failure. The evolving trends in the epidemiologic factors and treatment of hospitalised patients with congestive heart failure in Shanghai during the years 1980, 1990 and 2000. Zhonghua Xin Xue Guan Bing Za Zhi. 2002;30:24-6.
20. Ma JP, Wang L, Dang Q, Li YJ, Li XY, Zhang CZ, et al. Retrospective analysis of drug treatment on inpatients with chronic heart failure. Zhonghua liuxingbingxue zazhi. 2007;28(1):78-82.
21. Society of Cardiology Chinese Medical Association; Cheng K. Retrospective investigation of hospitalized patients with heart failure in some parts of China, in 1980, 1990 and 2000. Zhonghua Xin Xue Guan Bing Za Zhi. 2002;30(8):450-54.
22. Cao YM, Hu DY, Wu Y, Wang HY. A pilot survey of the main causes of chronic heart failure in patients treated in primary hospitals in China. Zhonghua Nei Ke Za Zhi [Chin J Int Med]. 2005;44(7):487-9.
23. Bai Y, Wang L, Hu S, Wei Y. Association of angiotensin-converting enzyme I/D polymorphism with heart failure: a meta-analysis. Mol Cell Biochem. 2012;361(1-2):297-304. doi: 10.1007/s11010-011-1115-8.
24. Andersson B, Sylven C. The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathic heart failure. J Am Coll Cardiol. 1996;28(1):162-7.
25. Ye S. Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome. Cardiovasc Res. 2006;69(3):636-45. doi: 10.1016/j.cardiores.2005.07.015.
26. Huang W, Xie C, Zhou H, Yang T, Sun M. Association of the angiotensin-converting enzyme gene polymorphism with chronic heart failure in Chinese Han patients. Eur J Heart Fail. 2004;6(1):23-7. doi: 10.1016/j.ejheart.2003.09.004.
27. Huang WY, Sun M, Zhou HY. Effect of the polymorphism of the angiotensin-converting enzyme gene on the plasma angiotensin II levels and the risk of chronic heart failure. Zhong nan da xue xue bao Yi xue ban (J Central South Univ Med Sci). 2004;29(2):198-200.
28. Hua Y, Song L, Wu N, Lu X, Meng X, Gu D, et al. Polymorphisms of MMP-2 gene are associated with systolic heart failure risk in Han Chinese. Am J Med Sci. 2009;337(5):344-8. doi: 10.1097/MAJ.0b013e31818eb2a2.
29. Gu D, Hua Y, Song L, Wu N, Xie G, Lu X. Polymorphisms of MMP-2 gene are associated with systolic heart failure prognosis. Circ Res. 2008;103(5):E53.
30. Hua Y, Song L, Wu N, Xie G, Lu X, Fan X, et al. Polymorphisms of MMP-2 gene are associated with systolic heart failure prognosis. Clin Chim Acta. 2009;404(2):119-23. doi: 10.1016/j.cca.2009.03.030.
31. Chinese Society of Cardiology of Chinese Medical Association - Editorial Board of Chinese Journal of Cardiology. Guideline for diagnosis and treatment of acute heart failure. Zhonghua Xin Xue Guan Bing Za Zhi (Chin J Cardiol). 2010;38(3):195-208.
32. Chinese Society of Cardiology of Chinese Medical Association Editorial Board of Chinese Journal of Cardiology. Chronic Heart Failure Treatment and Diagnosis Guideline in China 2007 Edition. Zhonghua Xin Xue Guan Bing Za Zhi (Chin J Cardiol). 2007;35(12).
33. Cao YM, Hu DY, Wang HY, Wu Y. A survey of medical therapies for chronic heart failure in primary hospitals in China. Zhonghua Nei Ke Za Zhi (Chin J Int Med). 2006;45(11):907-9.
34. Fan WF. Cross-sectional survey on the current status of drug therapy in patients with stable heart failure in Shanghai. Zhonghua Xinxueguanbing. 2001;29(11):644-8.
35. Jiang T, Li DC, Liu ST. Medication dynamic analysis for patients with chronic heart failure in Minyang city in 1998, 2001 and 2004. Sichuan Med J. 2006;27:598-600.
36. Liao JT, Ding J, Wang Z. The study of quality of life in patients with congestive heart failure [Chinese]. Xin xue guan kang fu yi xue za zhi. 2001;10(5):404-6.
37. Jiang MX, Ruan XF, Xu Y. Effects of Kanlijian on exercise tolerance, quality of life, and frequency of heart failure aggravation in patients with chronic heart failure. Chin J Integr Med. 2006;12(2):94-100.
38. Riegel B, Moser DK, Glaser D, Carlson B, Deaton C, Armola R, et al. The Minnesota Living With Heart Failure Questionnaire: sensitivity to differences and responsiveness to intervention intensity in a clinical population. Nursing Res. 2002;51(4):209-18.
39. Leung KF, Liu FB, Zhao L, Fang JQ, Chan K, Lin LZ. Development and validation of the Chinese Quality of Life Instrument. Health Qual Life Outcomes. 2005;3:26. doi: 10.1186/1477-7525-3-26.
40. Huang CH, Chien KL, Chen WJ, Sung FC, Hsu HC, Su TC, et al. Impact of heart failure and left ventricular function on long-term survival-report of a community-based cohort study in Taiwan. Eur J Heart Fail. 2007;9(6-7):587-93. doi: 10.1016/j.ejheart.2007.02.008.
41. Zhao L, Liang KF, Liu FB. Psychometric properties of the chinese quality of life instrument in patients with chronic heart failure. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi (Chin J Integr Tradit West Med). 2006;26(9):784-7.
42. Zhao L, Leung KF, Liu FB, Chen J, Chan K. Responsiveness of the Chinese Quality of Life Instrument in patients with congestive heart failure. Chin J Integr Med. 2008;14(3):173-9. doi: 10.1007/s11655-008-0173-6.
43. He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Int Med. 2001;161(7):996-1002.
44. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol. 1993;22(4 Suppl A):6A-13A.
45. Li X-Y, Liao Y-H, Crawford B, Tanaka E, Wang D, Ariely R, et al. Real-world costs of reduced ejection fraction heart failure (HF-REF) from 5 regions of China [Abstract no. 2299 plus poster]. Value in Health. 2012;15(4):A129-30.